Prevention of ventricular fibrillation during acute myocardial ischemia: Control of free fatty acids

Journal of Cardiovascular Pharmacology and Therapeutics

Volumn 6, Issue 3, 2001, Pages 213-217

  Oliver, M F ^a  

^a NONE   (United Kingdom)

Author keywords

Free fatty acids; Myocardial ischemia, lipolysis; Ventricular fibrillation

Indexed keywords

ANTILIPEMIC AGENT; CATECHOLAMINE; FATTY ACID; GLUCOSE; LIPOPROTEIN LIPASE;

DISEASE PREDISPOSITION; DRUG EFFECT; DRUG EFFICACY; DRUG MECHANISM; ENZYME ACTIVITY; ENZYME INHIBITION; FATTY ACID METABOLISM; GLUCOSE INFUSION; GLUCOSE UTILIZATION; HEART MUSCLE ISCHEMIA; HEART MUSCLE METABOLISM; HEART VENTRICLE FIBRILLATION; HUMAN; PRIORITY JOURNAL; REVIEW;

EID: 0035729343     PISSN: 10742484     EISSN: None     Source Type: Journal    
DOI: 10.1177/107424840100600301     Document Type: Review

References (41)

1. Ventricular fibrillation complicating myocardial infarction
2. Fatality outside hospital from acute coronary events in three British health district hospitals, 1994- 5
3. Electropharmacological control of cardiac arrhythmias: To delay conduction or to prolong refractoriness
4. Dispersion of 'refractoriness' in noninfarcted myocardium of patients with ventricular tachycardia or ventricular fibrillation after myocardial infarction
5. 1967-1997: Thirty years of cardiac arrhythmias
6. Metabolic derangement in ischemic heart disease and its therapeutic control
7. Modulation of responses to myocardial ischemia: Metabolic features of myocardial stunning, hibernation, and ischemic preconditioning
8. Decade of clinical trials: CAST to AVID
9. Initial metabolic and hormonal response to acute myocardial infarction
10. Free noradrenaline and adrenaline excretion in relation to clinical syndromes following myocardial infarction
11. Serum-free-fatty-acids after acute myocardial infarction and cerebral vascular occlusion
12. Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction
13. Metabolic responses of the heart in acute myocardial infarction in man
14. Relationship between carbohydrate and lipid metabolism and the energy balance of the heart
15. Essential fuels for the heart and mechanical restitution
16. Optimizing cardiac energy metabolism: A new approach to treating ischaemic heart disease
17. Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias
18. Effect of free fatty acids on myocardial functions and oxygen consumption in intact dogs
19. Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children
20. Fatty acid oxidation in the perfused ischemic heart
21. Relation between serum free fatty acids and arrhythmias and death after acute myocardial infarction
22. The transport and utilization of free fatty acid
23. A metabolic cause for arrhythmias during acute myocardial hypoxia
24. Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction
25. The role of free fatty acids in the production of ventricular arrhythmias after acute coronary artery occlusion
26. Arrhythmias following infusions of fatty acids
27. Dietary lipid modulation of ventricular fibrillation threshold in the marmoset monkey
28. Prevention of sudden cardiac death by dietary pure ω-3 polyunsaturated fatty acids in dogs
29. Cardiac fatty acid metabolism and the induction of apoptosis
30. Metabolic approaches in ischaemic heart disease
31. Control of ventricular arrhythmias during myocardial infarction by antilipolytic treatment using a nicotinic acid analogue
32. Effect of inhibition of lipolysis on infarct size after experimental coronary artery occlusion
33. Anti-lipolytic therapy in angina pectoris: Reduction of exercise-induced ST segment depression
34. Β-blockade after myocardial infarction: Systematic review and meta regression analysis
35. Effects of ranolaxine on ischemic threshold, coronary sinus blood flow and myocardial metabolism in coronary artery disease
36. Glucose-insulin-potassium (GIK) for acute myocardial infarction: A negative study with a positive value
37. Lipoprotein and hepatic lipase in lipoprotein metabolism
38. Treating ischemic heart disease by pharmacologically improving cardiac energy metabolism
39. Metabolic modulation of acute myocardial infarction. The ECLA glucose-insulinpotassium pilot trial
40. Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus
41. Prognostic implications of ventricular fibrillation in acute myocardial infarction: New strategies required for further mortality reduction